Who
Anna Shlimak
Officer
Company insider
Files Form 4 as: SVP, Corporate Affairs, Cronos Group.
In numbers
- Trades disclosed
- 71
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Jun 2020
- Last trade
- 19 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Mar 2026filed 20 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —28,429 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $25K9,767 at $2.54 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —28,429 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —28,429 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —28,429 at $0.00 | filing |
| 19 Mar 2026filed 20 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $25K9,767 at $2.54 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —45,226 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $41K16,354 at $2.50 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —45,226 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —45,226 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —45,226 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $41K16,354 at $2.50 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —47,368 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $44K17,230 at $2.56 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —47,368 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —47,368 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code M | —47,368 at $0.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CRON Cronos GroupPharmaceuticals | SEC FORM 4 Code F | $44K17,230 at $2.56 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —166,459 at $0.00 | filing |
| 9 Mar 2026filed 10 Mar 2026 | CRON Cronos Groupoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —23,134 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.